StockNews.com Initiates Coverage on GlycoMimetics (NASDAQ:GLYC)
StockNews.com started coverage on shares of GlycoMimetics (NASDAQ:GLYC – Free Report) in a research report report published on Tuesday morning. The firm issued a sell rating on the biotechnology company’s stock. GlycoMimetics Trading Up 23.8 % NASDAQ:GLYC opened at $0.36 on Tuesday. The firm’s fifty day simple moving average is $0.26 and its 200 day […]
